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ABSTRACT 
Objective: In this study, a polysaccharide isolated from the seeds of Cajanus cajan (pigeon pea) was investigated as a super disintegrant in the 
orodispersible tablets of diclofenac sodium. 
Methods: Diclofenac sodium tablets were prepared separately using different concentrations (5%, 7.5%, 10%, and 15% w/w) of isolated Cajanus 
cajan seed polysaccharide (natural) and sodium starch glycolate (synthetic) as super disintegrant by the direct compression method. Evaluation of 
tablets was done for various pre-and post-compression parameters. The stability studies were performed on optimized formulation F5. The 
disintegration time and in vitro drug release of the formulation F5 was compared with pregelatinized starch and synthetic super disintegrant 
(sodium starch glycolate).  
Results: The drug-excipient interactions were characterized by Fourier transform infrared studies. The Optimized formulation F5 containing 15% 
polysaccharide showed wetting time of 118.7 seconds with 105.3 seconds of disintegration time and 95.61% dissolved in 3 min.  
Conclusion: The present work revealed that Cajanus cajan seed polysaccharide has a good disintegrating agent in the formulation of orodispersible 
tablets.  
Keywords: Diclofenac sodium, Pigeon starch, Sodium starch glycolate, Orodispersible tablets (ODTs) 




Orodispersible tablets (ODTs) are solid dosage forms containing 
medicinal substances which disintegrate rapidly, usually in a matter 
of seconds, when placed on a tongue. ODTs taken without 
administration of water, it shows better patient compliance [1, 2].  
The technologies utilized for the preparation of ODTs include 
lyophilization, direct compression, moulding, cotton candy process, 
spray drying, sublimation, mass extraction, and quick dissolving film 
formation. These techniques are based upon the principles of 
increasing porosity and the addition of super disintegrants and 
water soluble excipients in the tablets [2-4]. Natural polymers are 
ubiquitous material in the plant world and most useful to humans as 
food preparations, binding agent, disintegrating agent, and thickener 
[5]. They act as vehicles which transport the incorporated drug to 
the site of absorption and are expected to guarantee the stability of 
the incorporated drug, the precision, and accuracy of the dosage, and 
also improve the organoleptic properties of the drugs [6]. Native 
starch can be modified, causing a change in its physical and chemical 
parameters. These changes may be achieved by altering starch 
properties such as pasting temperature, viscosity, surface charge 
and hydrophilic/hydrophobic nature [7]. 
Excipients from natural sources have an advantage over synthetic 
excipients in that they are eco-friendly, biocompatible, local 
accessibility, low price, nontoxic, nonirritating when compared to 
synthetic excipients. Examples of natural excipients are Lepidus 
sativum, locust bean gum, isapghula husk, hibiscus, fenugreek [8]. 
Cajanus cajan common names are red gram, congo pea, gungo pea, 
arhar, pigeon pea. Chemically C. cajan containing cajanin, 
pinostrobin, longistylin, vitexin, orientin. C. cajan has several 
medicinal uses mostly used as relief of pain in traditional Chinese 
medicine and as a sedative [9]. Diclofenac Sodium is a phenyl-acetic 
acid derivative, Analgesic and anti-inflammatory drug belonging to 
the category of a preferential COX-2 inhibitor. The molecular weight 
of diclofenac sodium is 318.13 g/mol, and its half-life is 1-2 h. It is 
mainly used as a sodium salt for the relief of pain and inflammation 
in various conditions [10]. The present research work was aimed at 
the formulation and evaluation of ODTs of diclofenac sodium by 
direct compression method using a natural super disintegrant to 
produce a rapid onset of action and better patient compliance.  
MATERIALS AND METHODS  
Materials 
Diclofenac sodium, Aspartame, Sodium starch glycolate was 
obtained from Yarrow Chem. Products of Mumbai, India. Lactose 
monohydrate was obtained from Finar Chemicals Ltd, Ahmedabad, 
India. Talc was obtained from Loba Chemie Pvt. Ltd., Mumbai. 
Magnesium stearates were obtained from Moly Chem, Mumbai. 
Cajanus cajan seeds (Pigeon Pea) were collected from the local 
market. All reagents used were of analytical grade. 
Extraction of Pigeon pea starch 
Pigeon pea grains were washed repeatedly and milled into a fine 
paste using a laboratory blender. The slurry was strained through a 
fine muslin cloth and the filtrate was allowed to settle. The 
supernatant was decanted at 12 h intervals and the starch sediment 
was washed with distilled water. The starch sediment was spread on 
trays and placed in a hot air oven at 60 °C for 2 d. The dried mass 
pulverized using a mortar and pestle and a laboratory blender and 
the fine powder obtained was sieved using a sieve with the mesh 
size of 60 mm. The obtained starch was weighed and stored in an 
airtight container. 
Pregelatinization of pigeon pea starch 
15 g of pigeon pea starch was weighed and 5 ml of water added and 
placed over boiling water-bath. The mixture was continuously 
stirred over the water bath and 30 ml of water was added again with 
continuous stirring. This process was continued until the starch was 
well prepared using 73 ml of water in all. The prepared 
Pregelatinized starch was dried in a hot air oven at 60 °C for 24 h 
shown in fig. 1d. 
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Fig. 1: (a). Sedimentation of Pigeon pea starch; (b). Separation of pigeon pea starch; (c). After drying the Pigeon pea starch; (d) 
Pregelatinized starch 
 
Formulation of ODTs 
ODTs of diclofenac sodium were prepared by direct compression 
method using natural super disintegrant at the concentrations of 5%, 
7.5%, 10%, and 15% w/w. All the ingredients are passed through the 
60 mesh sieve. A weighed quantity of each ingredient was taken, and 
the powder blend was uniformly mixed and compressed into tablets of 
200 mg using 8-mm round flat punches on a rotary punching machine 
(Rimek Tabletting Machine (Karnavti Engg, Ahmedabad)). The 
composition of each formulation is given in table 1. 
 
Table 1: Formulation of tablets by direct compression method 
Ingredients Formulation code 
F1 F2 F3  F4 F5 F6 F7 F8 F9 F10 
Diclofenac Sodium 100 100 100 100 100 100 100 100 100 100 
Pigeon pea starch - 10 15 20 30 - - - - - 
Pregelatinized Starch - - - - - 10 15 20 30 - 
Sodium starch glycolate - - - - - - - - - 30 
Lactose monohydrate 95 85 80 75 65 85 80 75 65 65 
Aspartame 1 1 1 1 1 1 1 1 1 1 
Talc 2 2 2 2 2 2 2 2 2 2 
Magnesium stearate 2 2 2 2 2 2 2 2 2 2 
Total weight (mg) 200 200 200 200 200 200 200 200 200 200 
 
Swelling capacity 
10 g of pigeon pea starch was weighed and put in a 100 ml of 
measuring cylinder. The tapped volume (Vx) occupied by the 
powder was determined and recorded. About 20 ml of distilled 
water was added to form a dispersion of the starch. The dispersion 
was made up of the 100 ml of water and allowed to settle [10]. The 
dispersion was allowed to stand for 24 h before the sedimentation 
volume (Vv) was measured and the swelling capacity was calculated 







Angle of repose 
The angle of repose (θ) was carried out by using the fixed funnel 
method. Accurately weighed required quantity of powder mixture 
was taken in a funnel. The height of the funnel was adjusted in such 
a way that the tip of the funnel just touched the apex of the heap of 
the pile. The powder was allowed to flow through the funnel without 
any resistance on to the surface. Finally, the diameter and height of 
the powder were measured [11]. The angle of repose was calculated 
using the following equation:  




Where h and r are the height and radius of the powder cone 
respectively.  
Determination of bulk and tapped densities 
Approximately 10 g of powder was weighed and transferred into a 
100 ml measuring cylinder. The cylinder was gently twisted to 
obtain a levelled surface of the powder. The initial volume occupied 
in the cylinder was noted as the Bulk density. The powder in the 
cylinder was then tapped 100 times at a time and the new volume 
occupied after each round of tappings noted as the Tapped density. 
The tapping was continued until no further change in volume was 
noted [11]. Bulk density and Tapped density were calculated using 
the following formula:  
Bulk density =  
Weight of the powder
 bulk volume 
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Tapped density =
Weight of the powder
Tapped volume
 
Compressibility index and Hausner’s ratio 
The compressibility index and the Hausner’s ratio have become the 
simple, fast and popular methods of predicting powder flow 
characteristics [12]. The compressibility index and Hausner’s ratio 
were determined by measuring both the bulk density and tapped 
density of granules:  
 ompressibility index =





 bulk density 
 
Tablet hardness 
Hardness is an important parameter that prevents breakage of 
tablets during storage, transportation, and handling. Hardness can 
be measured by using Monsanto hardness tester and was expressed 
in terms of kg/cm2 [13]. 
Tablet thickness 
The tablet was placed between the two arms of the vernier callipers, 
and the thickness was measured. Five measurements were taken 
[14]. 
Weight variation 
20 tablets were selected randomly from each formulated batch and 
weighed individually. The individual weights were compared with 
the average weight for the weight variation [15]. 
Friability 
Friability is a measure of mechanical strength of the tablet. If a tablet 
has more friability it may not remain intact during packaging, 
transport, and handling. 5 tablets were measured and placed in a 
USP type Roche friabilator. The friability was checked at 25 rpm that 
is 100 revolutions for 4 min. Then the tablets were dusted and 
reweighed. The weight loss should not be more than one per cent 
[16]. The percentage weight loss (friability) was calculated as:  
Friability =
Initial weight of the tablet − Final weight of the tablet
Initial weight of tablet
× 100 
Drug content 
10 tablets were randomly weighed and crushed to fine powder, and a 
quantity of powder equivalent to 50 mg of diclofenac sodium was put 
in a 100 ml of volumetric flask and diluted with methanol. Then the 
solution was filtered finally made up to 100 ml using PH 6.8 phosphate 
buffer. The diclofenac sodium content was determined by measuring 
the absorbance at 280 nm using a UV-Visible Spectrometer (Aligent 
technology, Malaysia). The drug content was determined using the 
standard calibration curve. The mean per cent drug content was 
calculated as an average of three determinations [11, 23].  
Wetting time  
Wetting time is an important parameter. It helps in studying the 
effect of different excipients in the disintegration of the tablet. A 
piece of tissue paper folded twice was placed in a small Petri dish 
containing 6 ml of pH 6.8 phosphate buffer and add one millilitre of 
water containing amaranth (water soluble dye), a tablet was put on 
the paper, and the time for complete wetting was measured. Three 
trials for each batch were performed and the standard deviation was 
also determined [17]. 
Water absorption ratio (R)  
The weight of the tablet before keeping in the Petri dish was noted 
(Wb). Fully wetted tablet from the Petri dish was taken and 
reweighed (Wa) [17]. Water absorption ratio(R) was determined by 
using the following equation:  




Where Wb and Wa denote the tablet weights before and after water 
absorption respectively.  
In vitro disintegration time 
Disintegrating apparatus is used. It consisting of a wire basket of 3 
cm height and 2 cm diameter and mesh size of # 10 is placed above a 
beaker containing 900 ml of pH 6.8 phosphate buffer. The assembly 
is supported with a heater to maintain the temperature at 37 °C and 
a magnetic stirrer. Orodispersible tablets should be disintegrating 
within seconds [18]. 
In vitro dispersion time 
In vitro dispersion time was done as an assessment of the grittiness 
which arises due to the disintegration of the tablet into coarse 
particles. The test was performed by placing two tablets in 100 ml 
water and stirring gently until the tablets get completely 
disintegrated. The formulation is considered to form a smooth 
dispersion if the complete dispersion passes through a sieve screen 
with a nominal mesh aperture of 710μm without leaving any residue 
on the mesh [19]. 
In vitro dissolution 
Paddle type dissolution apparatus containing 900 ml of pH 6.8 
phosphate buffer as dissolution medium, maintained at 37±0.5 °C 
and with a stirring speed of 100 rpm was employed to assess the in 
vitro drug release characteristics of the tablet. Orodispersible tablets 
from each formulated batch containing an equivalent of 100 mg of 
the drug were weighed accurately and placed inside the dissolution 
medium. The whole process was carried out under sink condition 
for 15 min. At predetermined time intervals, sample (5 ml 
dissolution medium) were collected and passed through filter paper. 
Immediately an equal volume of fresh medium (maintained at 
37±0.5 °C) was used as replenishment. Withdrawn samples were 
diluted suitably and assayed spectrophotometrically at the detected 
λ max values of the respective drug in the same medium. At this 
wavelength, the tablet interferes with the absorption of the drug in 
the medium. For each batch, the experiment was followed for six 
times [15].  
Drug excipients interaction study 
The drug and excipient interactions were studied using Fourier 
transform infrared spectroscopy (IR-Prestige 21, Shimatzu make, 
Japan). The pure drug, the mixture of the drug with the polymer 
(1:1), and the optimized formula (a mixture of the drug with various 
excipients used in the preparation of ODT formulation) were 
characterized by Fourier transform infrared spectroscopy so the 
compatibility can be determined. The scanning range was 400-4000 
cm-1 and IR spectra of samples were obtained using the KBr disc 
method. Differential scanning calorimetry (DSC) was performed 
using PerkinElmer instruments, Singapore. The thermograms of 
pure diclofenac sodium and physical mixture of drug and excipients 
were obtained at a scanning range of 10 °C/minute conducted over a 
temperature range of 30-300 °C. ODT tablets were subjected to XRD 
(Ultima111 instrument, Rigaku make Japan), with Cu-Kα radiation 
(400KV, 30Ma, and scan speed 1/minute) to investigate the physical 
state of diclofenac sodium [20, 22]. 
RESULTS  
FTIR spectrum of pure diclofenac sodium by KBr pellet method was 
shown in fig. 2. The FTIR of the pure drug was characterized peak at 
around 1602.85 cm-1 C=C and COOH-Carboxylic acid group 
stretching at 3203.76 cm-1and N-H (amine) group stretching at 
3387.00 cm-1were observed. Before the formulation of the dosage 
form, drug-excipients studies were done through visual inspection 
and FTIR. The drug alone and combination with other polymers are 
placed in vials for 3 to 4 mo. There is no significant difference in the 
colour of preparation during this period which means that there 
might not be any incompatibility present. The obtained FTIR spectra 
for the physical mixture are studied at 4000 cm-1to 400 cm-1and 
shown in the fig. 3. FTIR result showed no major shift in the peaks 
which adds up to the conclusion that there might not be any 
incompatibility between the drug and the excipients. 
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Fig. 2: Fourier transform infrared spectrum of pure diclofenac sodium 
 
 
Fig. 3: Fourier transform infrared spectra for the physical mixture of drug and excipients 
 
The melting point of the pure drug (Diclofenac sodium) was 
determined using melting point and found to be in between 250-300 
°C. DSC curve obtained also shows the melting point temperature at 
283.38 °C as shown in fig. 4. DSC thermogram of the physical 
mixture formulation containing diclofenac sodium and pigeon pea 
seed starch was shown endothermic peak 273.42 shown in fig. 4. 
Thus DSC analysis confirmed that both drug and pigeon pea seed 
starch were compatible with each other. 
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The crystalline structure of pure diclofenac sodium was confirmed 
from the diffractogram obtained during the X-ray crystallographic 
study shown in fig. 5. The diffractogram of the physical mixture of drug 
and excipients displayed an identical pattern, but with a minor 
reduction in peak intensities shown in fig. 5. It demonstrates the 
homogeneous distribution of drug inside the tablet and the drug from 
crystalline to an amorphous state and it doesn't affect the therapeutic 
efficacy of the drug as all the functional groups were present. 
 
 
Fig. 5: X-Ray analysis of formulation F5, pigeon pea starch and diclofenac sodium 
 
Table 2: Physicochemical characterization of powder blend 
Formulation 
code 










F1 38±1.01 0.65±0.5 0.81±0.16 22.0±0.05 1.21±0.032 
F2 27.4±0.2 0.47±0.02 0.61±0.01 13.43±1.20 1.17±0.026 
F3 26.1±0.2 0.46±0.04 0.62±0.02 15.16±1.43 1.19±0.052 
F4 25.7±0.5 0.48±0.02 0.56±0.05 14.08±1.60 1.27±0.031 
F5 24.8±0.9 0.46±0.03 0.64±0.31 15.23±0.53 1.18±0.025 
F6 28.6±0.2 0.48±0.12 0.53±0.02 14.67±0.40 1.26±0.015 
F7 27.9±0.6 0.45±0.15 0.61±0.05 14.28±1.56 1.21±0.004 
F8 26.4±0.2 0.44±0.01 0.58±0.02 13.56±0.05 1.19±0.021 
F9 25.9±0.9 0.42±0.06 0.51±0.01 12.81±0.84 1.15±0.035 
F10 28.8±0.1 0.48±0.02 0.56±0.05 14.08±1.35 1.27±0.033 
(mean±SD, n=3) 
 
The angle of repose of formulation blend was found to be 24.8 to 
28.8, which indicate the good flow of the drug. The Carr's index was 
found to be in the range of 12.81 to 22.0 indicating good 
compressibility of the powder. Hausner's ratio was found in the 
range of 1.15 to 1.27 is good as reported in table 2. The formulation 
of ODTs of diclofenac sodium using natural super disintegrant and 
all formulations can be prepared by direct compression method. The 
natural polymer extracted from C. Cajan seeds was a light brown 
coloured powder. Carr's index and angle of repose indicated that the 
natural super disintegrant has good flow properties. 
 
Table 3: Post compression parameters of diclofenac sodium orodispersible tablets 
 Formulation code Thickness (mm) Hardness (kg/cm2) Friability (%) Weight variation(mg) 
F1 2.14±0.02 4.7±0.20 0.6±0.03 200.1±0.51 
F2 2.19±0.03 4.6±0.18 0.5±0.01 200.1±0.55 
F3 2.32±0.05 4.6±0.17 0.5±0.01 200.2±0.14 
F4 2.37±0.08 4.5±0.14 0.5±0.03 200.3±1.46 
F5 2.29±0.03 4.1±0.11 0.5±0.03 200.1±1.50 
F6 2.17±0.10 4.5±0.17 0.6±0.02 199.8±0.62 
F7 2.22±0.08 4.5±0.15 0.6±0.01 200.4±0.57 
F8 2.27±0.06 4.3±0.12 0.5±0.01 200.3±0.53 
F9 2.31±0.13 3.8±0.12 0.5±0.02 200.1±0.55 
F10 2.18±0.04 4.7±0.19 0.5±0.04 200.1±1.45 
(mean±SD, n=3) 
 
The hardness of the tablets was determined and was found to be in 
the range of 3.8-4.7 kg/cm². Friability was observed to be between 
0.5%-0.6%, which was less than 1% indicating that the tablets had 
good mechanical resistance. The results of the post-compression 
parameters are summarized in table 3 and 4. 
The wetting time and water absorption ratio are important 
criteria for understanding the capacity of a disintegrant to swell 
in the presence of a small amount of water. The wetting time for 
all formulations was found to be between 58.22±0.46 to 
195.12±1.62 s. The in vitro disintegration time for the 
formulations F1 to F10 is summarized in table 4. The in vitro 
drug release rate from the formulations containing natural super 
disintegrant was found to be rapid when compared to the 
formulation containing sodium starch glycolate. The in vitro drug 
release profile of the formulations F1 to F10 are represented in 
fig. 6, 7 and 8. 
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Table 4: Post compression parameters of Diclofenac sodium orodispersible tablets 
Formulation code In vitro disintegration time (s) In vitro dispersion test (s) Wetting time (s) Water absorption ratio 
F1 237.2±1.35 125±1.32 195.12±1.62 40.02±0.21 
F2 167.1±0.24 58.2±0.53 145.10±0.29  42.73±0.25 
F3 144.2±0.39 55.7±0.89 141.34±0.25 45.23±0.32 
F4 135.5±0.68 50.3±0.62 131.15±0.33 47.08±0.24 
F5 105.3±0.57 48.6±0.30 118.17±0.21 48.05±0.28 
F6 179.2±0.48 68.8±1.74 90.23±0.35 50.12±0.47 
F7 159.4±0.67 60.0±1.52 80.08±0.42 50.73±0.36 
F8 153.3±0.63 56.8±1.68 66.47±0.39 51.45±0.59 
F9 140.5±0.41 50.4±1.24 58.22±0.46 52.38±1.34 




Fig. 6 :  In vitro drug release profile of formulations F1,F2,F3 and F4. (Values are expressed as mean±SD, n=3) 
 
 
Fig.7:  In vitro drug release profile of formulations F5,F6 and F7. (Values are expressed as mean±SD, n=3) 
 
 
Fig. 8:  In vitro drug release profile of formulations of F8,F9, and F10 (Values are expressed as mean±SD, n=3) 
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Table 5: In vitro drug release profile of ODTs of Diclofenac sodium 
Time (min) In vitro drug release profile of ODTs of Diclofenac sodium from F1 to F5 
F1 F2 F3 F4 F5 
0 0 0 0 0 0 
1 21.94±0.54 27.44±0.65 29.24±0.54 39.77±0.86 42.99±0.64 
2 33.41±0.43 33.37±0.75 42.90±0.64 66.32±0.43 60.70±0.85 
3 56.93±0.74 68.41±0.64 57.02±0.75 71.62±0.75 95.61±0.43 
4 68.4±0.21 75.91±0.32 76.68±0.65 82.98±0.43  
5 76.77±0.65 87.95±0.64 82.83±0.32 96.85±0.56  
6 83.7±0.35 89.81±0.68 91.64±0.98   
7 83.57±0.75 94.18±0.84    
8 84.13±0.32     
9 84.38±0.87     
10 86.67±0.97     
11 88.57±0.56     
12 85.64±0.54     
13 82.83±0.77     
14 76.81±0.56     
15 76.59±0.79     
(mean±SD, n=3) 
 
Table 6: In vitro drug release profile of ODTs of Diclofenac sodium 
Time (min) In vitro drug release profile of ODTs of Diclofenac sodium from F1 to F5 
F6 F7 F8 F9 F10 
0 0 0 0 0 0 
1 19.71±0.21 11.51±0.35 8.83±0.35 6.12±0.35 20.02±0.35 
2 32.56±0.35 29.46±0.24 20.55±0.54 11.33±0.46 37.74±0.52 
3 50.18±0.51 41.18±0.65 31.96±0.36 18.58±0.31 52.46±0.35 
4 81.18±0.54 53.36±0.45 58.69±0.45 36.82±0.65 71.19±0.69 
5 84.53±0.25 73.17±0.57 74.42±0.36 48.30±0.95 89.31±0.36 
6 91.48±0.74 85.22±0.64 83.48±0.64 53.48±0.5 92.63±0.52 
7  90.74±0.22 90.37±0.32 64.21±0.36 96.92±0.35 
8    68.08±0.51 98.13±0.38 
9    72.77±0.69 101.01±0.25 
10    74.82±0.32  
11    79.07±0.21  
12    85.09±0.25  
13    88.75±0.65  
14    90.34±0.45  




The formulation of ODTs was made by diclofenac sodium using 
natural super disintegrant (Cajanus cajan). It has good swelling 
property. So, we have observed that the selected natural super 
disintegrant was found to be suitable in formulating ODTs of 
diclofenac sodium. ODTs of diclofenac sodium were prepared by 
direct compression method using different concentrations (5%, 
7.5%, 10%, and 15%) of C. Cajan as a natural super disintegrant and 
sodium starch glycolate (15%) as a synthetic super disintegrant. 
The physicochemical properties of the starches are presented in 
table 2. The bulk density of the native starch was significantly 
different from Pregelatinized Starch. The disintegration time values 
for all the formulations containing native starch (NAS) had the low 
disintegration time values, the rank order was native starch 
(NAS)>pregelatinized starch (PG)>sodium starch glycolate (SSG). 
The least dissolution values were obtained from the native starch, 
which can be correlated with the swelling capacity of the starch. The 
highest disintegration time observed for SSG. The ranking order was 
NAS>PG>SSG. In vitro dispersion and water absorption ratio of 
native starch shows a better result than that of pregelatinized and 
sodium starch glycolate. The ranking order was NAS>PG>SSG. 
Native starch had high wetting time values when compared to other 
formulations. The ranking order was PG>NAS>SSG, because some 
quantity of water was added to pregelatinized starch and heated to 
boiling water bath. So, the prepared gelatinized solution containing 
hydration capacity. Tablets containing pigeon pea starch 15 % w/w 
(F5) showed better drug release (95.61 %) at 3 min compared to 
that of 5 % w/w (F2), 7.5 % w/w (F3), 10 % w/w (F4) as shown in 
table 5 and 6. Tablets containing Pregelatinized starch 5 % w/w (F6) 
showed better drug release (91.48 %) at 6 min compared to that of 
7.5 % w/w (F7), 10 % w/w (F8), 15 % w/w (F9) as shown in table 5 
and 6. Tablets containing sodium starch glycolate 15 % w/w (F10) 
showed drug release (92.63) at 6 min. In all the ten formulations F5, 
F6 and F10 formulations containing 15 % w/w, 5 % w/w and 15 % 
w/w concentrations of pigeon pea starch, pregelatinized starch, 
sodium starch glycolate showed higher drug release in less time 
compared to other formulations. Among all the formulations F5 
formulation containing 15 % w/w pigeon pea seed starch showed 
the rapid drug release (95.61 %) within 3 min. It was observed that 
the % drug release increased within concentration of the 
disintegrant and decreases in time. In the present research work, the 
quantity of pigeon pea seed starch used for the designing of the 
ODTs is less than the above mentioned quantities in ayurvedic 
system of medicine. So, they are safe to use and also effectively used 
as a natural super disintegrants [24]. 
The drug release of the F5 formulation was rapid and better 
compared to the other formulations. The formulation F5(15%) 
natural super disintegrants showed a rapid disintegration, 
dissolution time, in vitro dispersion time and water absorption ratio 
as compared with the formulation prepared using a synthetic super 
disintegrants at the same concentration level. Hence, batch F5 was 
considered the optimized formulation.  
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CONCLUSION 
From this work, concluded that the native and modified form of 
pigeon pea starch (C. Cajan) is a potential candidate for use as a 
disintegrant in the formulation of ODTs. Because C. cajan is 
inexpensive, nontoxic, compatible and easy to manufacture, 
compared to synthetic super disintegrant. So, it can be used in place 
of commercially available synthetic super disintegrant. The 
prepared tablets also offer further advantages in terms of patient 
compliance, quick onset of action, high bioavailability, and good 
stability all of which make these tablets a better dosage form for the 
treatment of inflammation.  
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